Cardiff Oncology (CRDF) Income Annual - Discounting Cash Flows
Cardiff Oncology, Inc.
CRDF (NASDAQ)

* (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
2010
12-31
2009
12-31
2006
01-31
2005
01-31
Report Filing 2024-02-29 2023-03-02 2022-02-24 2021-02-25 2020-02-27 2019-03-06 2018-02-26 2017-03-15 2016-03-10 2015-03-12 2014-03-17 2013-04-01 2012-03-30 2010-12-31 2009-12-31 2006-05-16 2005-10-28
Revenue
0.49 0.39 0.36 0.37 0.24 0.38 0.50 0.38 0.31 0.28 0.26 0.45 0.26 0.27 0.65 0.00 0.00
Cost of Revenue
0.00 0.20 0.50 11.2 11.2 0.60 1.81 1.73 0.63 0.02 3.48 1.92 0.00 0.00 0.00 0.00 0.00
Gross Profit
0.49 0.19 -0.14 -10.9 -10.9 -0.22 -1.31 -1.35 -0.32 0.26 -3.22 -1.47 0.26 0.27 0.65 0.00 0.00
Operating Expenses
45.9 40.1 28.7 8.22 5.76 16.8 24.3 38.8 25.0 15.2 7.47 3.38 3.23 5.64 3.04 8.00 5.38
Research & Development
32.9 27.1 17.4 11.2 11.2 8.16 7.88 15.0 10.6 6.66 3.95 1.92 0.91 3.69 0.00 1.88 0.62
Selling, General and Administrative
13.0 13.2 11.8 8.22 5.76 8.01 14.2 23.0 14.4 8.54 7.00 3.38 2.32 1.95 2.22 2.53 0.65
Other Operating Expenses
0.00 -0.20 -0.50 -11.2 -11.2 0.66 2.17 0.79 0.00 0.00 -3.48 -1.92 0.00 0.00 0.82 3.59 4.11
Operating Income
-45.4 -39.9 -28.9 -19.1 -16.7 -17.1 -25.6 -40.1 -25.3 -14.9 -10.7 -4.85 -2.98 -5.38 -2.39 -8.00 -5.38
Net Non-Operating Interest
4.07 0.00 0.26 0.09 0.23 0.19 -0.74 -1.38 -1.47 -0.83 -0.01 0.00 -0.06 -0.12 0.09 0.13 0.00
Interest Income
4.07 1.58 0.26 0.09 0.23 0.22 0.15 0.00 0.06 0.01 0.00 0.00 0.00 0.00 0.00 0.13 0.00
Interest Expense
0.00 1.58 0.00 0.00 0.00 0.03 0.89 1.38 1.53 0.84 0.02 0.00 0.06 0.12 -0.09 0.00 0.00
Equity & Other Income/(Expense)
-0.10 1.20 0.30 -0.31 0.03 0.40 1.43 2.32 -0.73 1.45 -1.11 -6.72 0.76 0.16 -0.18 0.03 0.01
Income Before Tax
-41.4 -38.7 -28.3 -19.3 -16.4 -16.5 -24.9 -39.2 -27.5 -14.3 -11.8 -11.6 -2.28 -5.33 -2.48 -7.84 -5.37
Income Tax Expense
0.00 -1.20 -0.55 -0.03 -0.26 0.62 0.72 -0.30 1.82 0.61 0.02 6.68 -0.74 0.07 -0.18 0.00 0.00
Income Attributable to Non-Controlling Interest
0.00 0.00 0.00 0.00 0.00 -0.62 -0.72 0.30 -1.82 -0.61 -0.02 -6.68 0.70 0.05 0.18 0.00 0.00
Net Income
-41.4 -37.5 -27.7 -19.3 -16.2 -16.5 -24.9 -39.2 -27.5 -14.3 -11.8 -11.6 -2.24 -5.45 -2.48 -7.84 -5.37
Depreciation and Amortization
0.40 0.20 0.50 0.47 0.49 0.74 1.05 1.07 0.38 0.23 0.13 0.04 0.01 0.01 0.05 0.00 0.00
EBITDA
-45.0 -39.7 -28.4 -18.6 -16.2 -16.3 -24.5 -39.1 -24.9 -14.7 -10.6 -4.81 -2.97 -5.37 -2.34 -8.00 -5.38
Earnings Per Share (EPS)
-0.930 -0.860 -0.710 -0.920 -2.700 -7.060 -51.71 -93.54 -75.49 -54.56 -50.27 -63.87 -16.60 -54.81 -35.43 -0.420 -0.370
Diluted Earnings Per Share
-0.930 -0.860 -0.710 -0.920 -2.700 -7.060 -51.71 -93.22 -74.77 -54.08 -50.09 -63.73 -16.60 -54.81 -35.43 -0.420 -0.370
Weighted Average Shares Outstanding
44.7 43.6 39.0 20.9 5.97 2.33 0.48 0.42 0.36 0.26 0.23 0.18 0.13 0.10 0.07 18.5 14.6
Diluted Weighted Average Shares Outstanding
44.7 43.6 39.0 20.9 5.97 2.33 0.48 0.42 0.37 0.26 0.24 0.18 0.13 0.10 0.07 18.5 14.6
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us